Provided by Tiger Trade Technology Pte. Ltd.

Inspire Medical Systems

69.97
-0.8100-1.14%
Post-market: 69.970.00000.00%19:30 EDT
Volume:761.93K
Turnover:53.53M
Market Cap:2.01B
PE:15.19
High:71.74
Open:71.74
Low:68.44
Close:70.78
52wk High:147.03
52wk Low:38.91
Shares:28.80M
Float Shares:23.28M
Volume Ratio:0.77
T/O Rate:3.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.61
EPS(LYR):4.89
ROE:17.96%
ROA:3.91%
PB:2.44
PE(LYR):14.31

Loading ...

Truist Adjusts Price Target on Inspire Medical Systems to $62 From $54, Maintains Hold Rating

MT Newswires Live
·
Aug 04

UK's Smith & Nephew H1 Revenue Rises on Sports Medicine Strength

Reuters
·
Aug 04

Inspire Medical Systems Inc : Truist Securities Raises Target Price to $62 from $54

THOMSON REUTERS
·
Aug 04

Inspire Medical Systems Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Mobia Medical Appoints Myriam Curet, M.d., to Its Board of Directors

THOMSON REUTERS
·
Aug 04

Press Release: Mobia Medical Appoints Myriam Curet, M.D., to Its Board of Directors

Dow Jones
·
Aug 04

Inspire Medical Swings to Q2 Profit; Revenue Falls 7.6% to $200.6 Million

Reuters
·
Aug 04

Inspire Medical Systems Q2 Adj. EPS $0.14 Beats $(0.27) Estimate, Sales $200.581M Beat $194.671M Estimate

Benzinga Earnings
·
Aug 04

Inspire Medical Systems Outlook FY Adjusted Diluted EPS to be in the Range of $1.05 to $1.45

THOMSON REUTERS
·
Aug 04

Inspire Medical Systems Q2 EPS USD 0.01

THOMSON REUTERS
·
Aug 04

Inspire Medical Systems Inc: Expects Majority of Actions Related to Restructuring to be Completed in Q3

THOMSON REUTERS
·
Aug 04

Inspire Medical Systems - Expects $20 Mln-$25 Mln Pre-Tax Restructuring Charges for Project Horizon

THOMSON REUTERS
·
Aug 04

Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan

THOMSON REUTERS
·
Aug 04

Inspire Medical Systems Coverage Assumed by UBS at Sell vs Previous Rating of Neutral

Dow Jones
·
Jul 29

UBS Downgrades Inspire Medical Systems to Sell From Neutral, Cuts Price Target to $39 From $67

MT Newswires Live
·
Jul 28

Inspire Medical assumed with Sell from Neutral at UBS

TIPRANKS
·
Jul 28

Inspire Medical Systems Inc : UBS Assumes Coverage with Sell vs Neutral Rating; Target Price $39 vs $67

THOMSON REUTERS
·
Jul 28

Earning Preview: Inspire Medical Systems this quarter’s revenue is expected to decrease by 9.15%, and institutional views are cautious

Earnings Agent
·
Jul 28

Inspire Medical Systems Appoints AtriCure CEO Michael Carrel to Board

Reuters
·
Jul 27

Press Release: Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to Its Board of Directors

Dow Jones
·
Jul 27